Location: Home
  • search
  • go
  • Relate News
  • 3/7/2025Recent Executive Moves
  • 3/6/2025Nhwa Pharma Acquires Stake in Neuro3 to Expand CNS Drug Pipeline  
  • 3/6/2025AI, Biomanufacturing, and Six Takeaways from China’s Government Work ...
  • 3/5/2025China to Adjust Centralized Drug Procurement Policies
  • 3/4/2025Amoytop's Strategic Acquisition of Skyline Assets Marks Expansion into...
  • 3/4/2025BeiGene's TEVIMBRA Approved in U.S. for First-line Treatment of Advanc...
  • 3/4/2025Trump's 'America First' Investment Policy Raises Uncertainty for US-Ch...
  • 2/28/2025NMPA Approves Multiple Drugs for Cancer, Cardiovascular, and Liver Dis...
  • 2/28/2025Recent Executive Moves
  • 2/27/2025HBM Alpha Enters License Deal to Advance Novel Endocrine Therapies
  • 2/27/2025Henlius Registers Phase 3 Trials for Keytruda and Yervoy Biosimilars
  • 2/27/2025Biokin (SystImmune) Initiates First Autoimmune Clinical Trial for Tetr...
  • 2/27/2025Novartis' NDA for BTK Inhibitor Remibrutinib Accepted by NMPA
  • 2/26/2025Hengrui Reports Promising Results for Trastuzumab Rezetecan in HER2-Mu...
  • 2/26/2025Chinese Biotech Firms Cash in on Promising Drug Discoveries via Licens...
  • 2/25/2025XellSmart Secures Second FDA IND Approval for iPSC-Derived ALS Therapy...
  • 2/25/2025Innovent's Dual Immunotherapy for Colon Cancer Advances with NMPA Prio...
  • 2/25/2025Pfizer to Study China-Originated Ivonescimab in ADC Combo Under Summit...
  • 2/25/2025China Launches Flagship Hospital Alliance to Advance Integrative Medic...
  • 2/21/2025FibroGen Sells China Subsidiary to AstraZeneca in $160 Million Deal
  • 2/21/2025China Unveils 2025 Action Plan to Boost Foreign Investment in Biotech ...
  • 2/21/2025MediLink's YL217 Received FDA Clearance of IND Application
  • 2/21/2025Recent Executive Moves
  • 2/21/2025Lessons from China's 2024 National Negotiation of Drug Prices (GT)
  • 2/20/2025Chimigen Secures CNY100M+ in Pre-A Financing to Advance Cancer and Hep...
  • 2/19/2025Pharma Industry Faces Uncertainty Amid Potential U.S. Tariffs on Chin...
  • 2/19/2025China Holds 2025 National Drug Regulation Conference, Setting Key Prio...
  • 2/18/2025Polymed Licenses IRAK4-Targeting Protein Degrader HPB-143 to Photys
  • 2/18/2025META Pharmaceuticals Completes Series A1 Financing Led by XtalPi
  • 2/18/2025Huadong Medicine Announces Positive Results from HDM1005 Clinical Tria...
  • Page:6/356 Total number of articles:10655: [First][<<] [4] [5] [6] [7] [8] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group